Document is current
Any future updates will be listed below
-
Authors
Barnabas, Ruanne V. https://orcid.org/0000-0002-1793-6003
Brown, Elizabeth R.
Onono, Maricianah
Bukusi, Elizabeth A.
Njoroge, Betty
Winer, Rachel L.
Donnell, Deborah
Galloway, Denise
Cherne, Stephen
Heller, Kate
Leingang, Hannah
Morrison, Susan
Rechkina, Elena
McClelland, R. Scott
Baeten, Jared M.
Celum, Connie
Mugo, Nelly
,
-
Funding
Funding for this research was provided by:
Bill and Melinda Gates Foundation (OPP1188693)
- License Information
-
More Information
Article History
Received: 19 May 2021
Accepted: 6 September 2021
First Online: 27 September 2021
Declarations
:
: The Kenya Medical Research Institute (KEMRI) Scientific and Ethics Review Unit (SERU), in Kenya, and the University of Washington Institutional Review Board, Seattle, WA, approved this study. The study was registered at ClinicalTrials.gov, number NCT03675256.All participants provided written informed consent, which included counseling about randomization, the vaccine used in each study group, strategies for cervical cancer prevention, and their rights as research participants.
: Declaration of interests: RVB reports grants from Bill and Melinda Gates Foundation, grants from National Institutes of Health, grants from Royalty Research Fund (UW), grants from King K. Holmes Professorship in STDs and AIDS, during the conduct of the study; and conference support from Regeneron Pharmaceuticals outside the submitted work. JMB reports grants from Bill & Melinda Gates Foundation during the conduct of the study; grants from BMGF, CDC, NIH, and USAID and personal fees from Gilead Sciences, Merck, and Janssen, outside the submitted work. CC reports grants from BMGF, during the conduct of the study, personal fees from Gilead Sciences, and personal fees from Merck, outside the submitted work. RLW reports grants from NIH and CDC during the conduct of the study. All other co-authors have nothing to disclose.
